Abbott India Ltd.

NSE: ABBOTINDIA | BSE: 500488 | ISIN: INE358A01014 | Industry: Pharmaceuticals
| Falling Comet
25955.0000 -145.00 (-0.56%)
NSE Jun 17, 2026 15:31 PM
Volume: 8,598
 

logo
Abbott India Ltd.
20 Apr 2020
25955.00
-0.56%
ICICI Securities Limited
On the business front, despite the nationwide lockdown, domestic growth is expected to remain more or less stable. Exports growth, barring for one or two months due to congestion in all major ports globally, is also expected to remain strong due to 1) currency benefit, 2) slowdown in competition due to delay in new approvals that will be beneficial for existing players and 3) expected demand continuum across the world despite Covid-19. Some windfall is also expected in some critical productsa case in point is Hydroxychloroquine, a malaria drug that is likely to be repurposed as a prophylaxis for Covid-19 treatment in some cases....
Abbott India Ltd. has an average target of 34456.75 from 4 brokers.
More from Abbott India Ltd.
Recommended